NRC Health Common Stock
NRC
73 hedge funds and large institutions have $162M invested in NRC Health Common Stock in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
47% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 19
40% more capital invested
Capital invested by funds: $116M → $162M (+$46.5M)
7% more funds holding
Funds holding: 68 → 73 (+5)
0.72% more ownership
Funds ownership: 28.09% → 28.81% (+0.72%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$2.82M |
| 2 |
BlackRock
New York
|
+$1.39M |
| 3 |
MCM
McKinley Capital Management
Anchorage,
Alaska
|
+$1.16M |
| 4 |
Millennium Management
New York
|
+$892K |
| 5 |
Renaissance Technologies
New York
|
+$851K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Spitfire Capital
Mill Valley,
California
|
-$5.24M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$1.82M |
| 3 |
WIC
Willis Investment Counsel
Gainesville,
Georgia
|
-$396K |
| 4 |
CIA
Capital Impact Advisors
Boston,
Massachusetts
|
-$281K |
| 5 |
JP Morgan Chase
New York
|
-$250K |
NRC Hedge Fund Activity: Q2 2017 in Review
73 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q2 2017, worth a combined $162M — up 40% from $116M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NRC positions and 4 closed out — a net gain of 5 holders — while 28 added to existing stakes and 19 trimmed.
The largest buyer was Royce & Associates, adding an estimated $2.82M. The largest seller was Spitfire Capital, cutting an estimated $5.24M.
- 73 institutional investors held NRC Health Common Stock (NRC) as of Q2 2017, up from 68 in Q1 2017.
- Funds reported $162M of NRC Health Common Stock stock for Q2 2017, up 40% quarter-over-quarter.
- 9 funds opened new NRC Health Common Stock positions in Q2 2017 and 4 closed out, a net change of +5 holders.
- The largest NRC Health Common Stock buyer in Q2 2017 was Royce & Associates, an estimated $2.82M added.
- The largest NRC Health Common Stock seller in Q2 2017 was Spitfire Capital, an estimated $5.24M sold.
Based on aggregated 13F filings for Q2 2017.